Eris Pharmaceuticals has formed the Australian Business Unit to cover the Australian and New Zealand (ANZ) markets by undertaking the promotion of its own brands, but also by representing key niche products that aim to improve the healthcare of the ANZ patients.
Eris Pharmaceuticals has established strategic collaborations with local distributors in emerging markets in order to bring product ranges in Prescription Medicine and dermocosmetics to these targeted areas.
The Australian Business Unit covers the needs of the Australian & New Zealand markets.
The Overseas Business Unit covers the activities and needs of the Emerging markets.